Press release
Dengue Vaccines Market Outlook for Major Applications/end Users, Consumption, Share and Growth Rate 2031
Dengue Vaccines Market: IntroductionAccording to the report, the global dengue vaccines market was valued at US$ 0.4 Bn in 2020 and is projected to expand at a CAGR of 11% from 2021 to 2031. Dengue is a mosquito-borne tropical disease caused by dengue virus. Symptoms usually begin three to 14 days after infection. These include high fever, vomiting, headache, muscle & joint pain, and a characteristic skin rash. A vaccine to prevent dengue (Dengvaxia) has been licensed, and is available in some countries for people aged between nine and 45 years. The World Health Organization recommends that the vaccine should only be given to persons with confirmed prior history of dengue virus infection. The vaccine manufacturer, Sanofi Pasteur, announced in 2017 that people who receive the vaccine and have not previously infected by the virus could be at risk of developing severe dengue, if they are infected after being vaccinated.
Read Report Overview: https://www.transparencymarketresearch.com/dengue-vaccine-market.html
Disrupted sanitation services and curtailed water supply lead to conditions that assist mosquito breeding and proliferation, while warm temperatures lead to longer active season for mosquitos. Climate change is likely to increase the burden of dengue, which, in turn, is anticipated to boost the growth of the global dengue vaccines market. The market in Asia Pacific is expected to expand at a high CAGR from 2021 to 2031, owing to highly developed healthcare sector, rise in prevalence of dengue, and continuous evolution of dengue vaccines. The region offers significant opportunities in the dengue vaccines market.
Request a Sample of Dengue Vaccine Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=28397
Increase in Incidence of Dengue to Drive Dengue Vaccines Market
The number of cases of dengue has increased over the past few years. Major regions of the world affected by dengue are the Americas, Africa, Southeast Asia, the Eastern Mediterranean, and the Western Pacific. Increase in incidence of dengue is likely to fuel the growth of the global dengue vaccines market during the forecast period.
Enquiry before Buying Dengue Vaccine Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=28397
Key Segmentation of Dengue Vaccines Market
In terms of category, the global dengue vaccines market has been divided into live attenuated vaccines, chimeric live attenuated vaccines, and others. The live attenuated vaccines segment accounted for 32.95% share of the global market in 2020. The segment is anticipated to expand at a CAGR of 10% from 2021 to 2031. In terms of product, the global dengue vaccines market has been bifurcated into CYD-TDV (Dengvaxia) and others. The CYD-TDV (Dengvaxia) segment accounted for 97.50% share of the market in 2020. The segment is likely to expand at a CAGR of 10.98% from 2021 to 2031.
Based on route of administration, the global dengue vaccines market has been classified into subcutaneous and others. The subcutaneous segment accounted for 75.62% share of the market in 2020. The segment is projected to expand at a CAGR of 11% from 2021 to 2031. Dengvaxia is given by the doctor or nurse as an injection underneath the skin (subcutaneous route) in the upper arm. Adults or children will receive three injections of 0.5 mL each at 6-month intervals. Currently, Dengvaxia is the only approved drug for dengue, which is used in dengue treatment.
In terms of end user, the global dengue vaccines market has been divided into hospitals, government institutes, specialty clinics, and others. The hospitals segment dominated the global market in 2020. The segment is anticipated to reach US$ 1.08 Bn by 2031.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=28397
Asia Pacific to Lead Dengue Vaccines Market
In terms of region, the global dengue vaccines market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific dominated the global dengue vaccines market in 2020, followed by Latin America. Asia Pacific’s significant market share can be ascribed to presence of a large number of key players, rise in prevalence of dengue, improving healthcare infrastructure, and funding from governments and large corporates. Brazil and Mexico are the leading markets in the region, due to the rise in investment in development of well-equipped health care institutions and rise in prevalence of dengue cases.
Buy now Dengue Vaccine Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=28397<ype=S
Competition Landscape of Dengue Vaccines Market
The global dengue vaccines market is fragmented in terms of number of players. Key players operating in the global market include Sanofi Pasteur Limited, Takeda Pharmaceutical Company Limited, Merck Co. & Inc., GlaxoSmithKline plc, GeneOne Life Science, Medigen Vaccine Biologics, Panacea Biotec Limited, Sun Pharmaceutical Industries Ltd., Serum Institute of India Pvt. Ltd., Biological E, and VabioTech.
More Trending Reports by Transparency Market Research:
https://www.prnewswire.co.uk/news-releases/carbon-therapy-segment-in-particle-therapy-market-to-grow-at-exponential-growth-rate-from-2018-to-2026-tmr-848789727.html
https://www.prnewswire.com/news-releases/strides-in-positive-airway-pressure-devices-market-help-reduce-worldwide-prevalence-of-obstructive-sleep-apnea-valuation-to-rise-at-cagr-of-7-8-from-2019-to-2027-tmr-301136571.html
https://www.prnewswire.co.uk/news-releases/closed-system-transfer-devices-market-to-observe-notable-growth-due-to-increase-in-use-of-oncology-drugs-and-emergence-of-novel-protocols-in-pharmaceutical-industry-says-tmr-825812545.html
Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dengue Vaccines Market Outlook for Major Applications/end Users, Consumption, Share and Growth Rate 2031 here
News-ID: 2482709 • Views: …
More Releases from Transparency Market Research

Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth.
Uncover essential discoveries and trends from…

Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth.
Discover essential conclusions and data from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100
Analysts' Viewpoint
The Technetium‐99m…

Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine…

Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,…
More Releases for Dengue
Key Trend Reshaping the Dengue Treatment Market in 2025: Innovative Drug Deliver …
Which drivers are expected to have the greatest impact on the over the dengue treatment market's growth?
The escalation in cases of dengue is projected to stimulate the expansion of the market for dengue treatments. Dengue is a viral infection transmitted by mosquito bites, causing symptoms akin to the flu and can escalate to intense complications if not treated. The escalation is primarily due to progressing urbanization, climate alterations favourable to…
Key Dengue Vaccine Market Trend for 2025-2034: Advancements In Dengue Tetravalen …
What Is the Future Outlook for the Dengue Vaccine Market's Size and Growth Rate?
In the past few years, the dengue vaccine market has experienced significant growth. From $0.64 billion in 2024, it is projected to reach $0.72 billion in 2025, marking a compound annual growth rate (CAGR) of 12.4%. This notable expansion during the historical period can be credited to factors such as an increase in travel and urbanization trends,…
Dengue Vaccine Market : An Detailed Overview
Introduction:
Dengue fever is a mosquito-borne viral infection caused by the dengue virus, transmitted primarily through Aedes aegypti and Aedes albopictus mosquitoes. Affecting millions globally each year, dengue has become a significant public health concern, especially in tropical and subtropical regions. The development of dengue vaccines represents a groundbreaking advancement in preventing the disease, reducing its associated healthcare costs, and controlling outbreaks. With increasing awareness and investments in immunization programs, the…
Dengue Vaccine Market : An Overview
Introduction:
Dengue fever is a mosquito-borne viral infection that has become a significant public health challenge in tropical and subtropical regions. The disease is caused by the dengue virus, which is transmitted primarily by Aedes aegypti mosquitoes. With approximately 390 million infections annually, dengue fever places a substantial burden on healthcare systems and economies worldwide. Efforts to mitigate this burden have led to the development of dengue vaccines, designed to prevent…
"Rising Incidence of Dengue Fever Propels Dengue Virus Diagnostic Tests Market T …
According to WHO, dengue affects about 50-100 million people worldwide, annually. It is a vector-borne highly communicable disease. This report discusses the diagnostic tests used to confirm the presence of dengue in one individual.
It is true that the growth of the global dengue virus diagnostic tests market is primarily driven by an increase in the incidence of dengue fever, which is a mosquito-borne viral infection that can cause severe flu-like…
Dengue Vaccines Market 2021 | Detailed Report
Dengue Vaccines Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027.
Get Free Sample PDF (including full TOC, Tables and Figures) of Dengue Vaccines Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4644240
The report provides a comprehensive analysis of company profiles listed below:
- Sanofi
- Takeda
Dengue Vaccines Market Segment by…